Through inhibiting monocytes infiltration and macrophages accumulation in TME, CCL2 intervention also suppressed the development of several types of tumor and promoted the better prognosis, including esophageal and breast cancers 71, 88. The gene discussed is CCL2; the disease is neoplasm.